Pharmacodynamics of Moxifloxacin against Streptococcus pyogenes in an In Vitro Kinetic Model

The aim of the present study was to investigate the pharmacodynamics of moxifloxacin against strains of Streptococcus pyogenes with different susceptibilities to erythromycin by using an in vitro kinetic model simulating human pharmacokinetics of moxifloxacin at oral doses of 400 and 200 mg, respect...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Odenholt, Inga, Löwdin, Elisabeth, Gustafsson, Ingegerd, Cars, Otto
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 2002
Sujets:	Experimental Therapeutics
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127214/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12019138/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.6.2046-2048.2002
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!